NCT02987777View on ClinicalTrials.gov

Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer

CompletedOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Endometrial Cancer

All Listed Sponsors

lead

Institut de Cancérologie de Lorraine

OTHER

NCT02987777 - Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer | Biotech Hunter | Biotech Hunter